On Wednesday, Shares of Streamline Health Solutions (NASDAQ: STRM) showed the bullish trend with a higher momentum of 2.79% and ended its trading session at $0.94. The company traded total volume of 864 shares as contrast to its average volume of 54.42K shares. The company has a market value of $18.20M and about 20.00M shares outstanding.
Streamline Health Solutions, Inc. (STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises, recently declared financial results for the second quarter and first half of fiscal 2018, which ended July 31, 2018.
Revenues for the three-month period ended July 31, 2018 reduced about 11% to $5.30M over the July 31, 2017 quarter revenue of $5.90M. Recurring revenue comprised 83% of total revenue in the quarter. Revenues for the first six months of fiscal year 2018 were $11.50M, down about 3% as contrast to $11.80M in the first half of fiscal 2017.
Net loss for the second quarter was $(1.50M) as contrast to a ($1.10M) net loss in the same period a year ago. Net loss for the first six months of fiscal 2018 was ($2.10M) as contrast to ($3.10M) net loss for the same period in 2017.
Adjusted EBITDA for the second quarter 2018 was $0.40M, down from $0.50M in the second quarter of 2017. Adjusted EBITDA for the first six months of 2018 was $1.00M, as contrast to $45.0K in the first half of fiscal 2017.
Highlights for the second quarter ended July 31, 2018 included:
- Revenue for the second quarter 2018 was $5.30M;
- Net loss for the second quarter 2018 was $(1.50M);
- Adjusted EBITDA for the second quarter 2018 was $0.40M;
- New sales bookings for the quarter were $1.90M; and
- Backlog at the end of the quarter was $23.40M.
The Company offered net profit margin of -8.50% while its gross profit margin was 61.80%. ROE was recorded as -20.40% while beta factor was 0.06. The stock, as of recent close, has shown the weekly upbeat performance of 2.76% which was maintained at -46.15% in this year.